JPLA
CPHI icon

Joseph P. Lucia & Associates’s China Pharma Holdings CPHI Stock Holding History

Joseph P. Lucia & Associates’s Portfolio CPHI Stock Details CPHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18
Closed -$4K – 454
2022
Q1 		$4K Buy
+18
New +$3.76K ﹤0.01% 365

Other funds holding CPHI

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Joseph P. Lucia & Associates's CPHI Position: Q2 2022 in Review

Joseph P. Lucia & Associates sold out of China Pharma Holdings (CPHI) in Q2 2022, closing a stake of 18 shares — an estimated $4K sold.

Joseph P. Lucia & Associates first reported a position in CPHI in Q1 2022 and held it in 1 quarter. The position peaked at $4K in Q1 2022. 8 funds tracked by Wall St. Rank hold CPHI as of Q2 2022.

  • Joseph P. Lucia & Associates reported no remaining China Pharma Holdings position as of Q2 2022 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 18 China Pharma Holdings shares in Q2 2022, an estimated $4K.
  • Joseph P. Lucia & Associates first reported a position in China Pharma Holdings in Q1 2022 and held it in 1 quarter.
  • Joseph P. Lucia & Associates's China Pharma Holdings position peaked at $4K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held China Pharma Holdings as of Q2 2022.

Based on Joseph P. Lucia & Associates's 13F filing for Q2 2022, filed 26 Jul 2022.